Skip to search formSkip to main contentSkip to account menu

neutropenic infection

Known as: infection neutropenic 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
PURPOSE We investigated whether capecitabine and docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide (FEC) or… 
2009
2009
Results of a randomized phase II trial of amrubicin (AMR) versus topotecan (Topo) in patients with extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based…
8028 Background: SCLC presents as ED-SCLC in 60%-70% of patients (pts). AMR, a synthetic anthracycline, is approved for these pts… 
Review
2009
Review
2009
Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer
PurposeCombination of intravenous (i.v.) vinorelbine and docetaxel was shown to be feasible and effective in metastatic breast… 
Review
2007
Review
2007
Reported Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity
To the Editor: I read with interest the article that reviewed the systemic toxicities of 247 consecutive procedures that used… 
2007
2007
Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
PurposeThe aim of this study was to investigate the combination of vinorelbine (VRL) alternating intravenous (i.v.) and oral in… 
2006
2006
BCIRG 007: Randomized phase III trial of trastuzumab plus docetaxel with or without carboplatin first line in HER2 positive metastatic breast cancer (MBC).
LBA516 Background: Based on preclinical synergism between docetaxel (T), carboplatin (C) and trastuzumab (H), BCIRG conducted a… 
Review
2005
Review
2005
Phase II Study of Low-Dose Docetaxel/Fluorouracil/Cisplatin in Metastatic Gastric Carcinoma
Objectives:In several recent reports, docetaxel (75–85 mg/m2) combined with fluorouracil (5-FU) and cisplatin has shown… 
2003
2003
Aggressive Simultaneous Radiochemotherapy with Cisplatin and Paclitaxel in Combination with Accelerated Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Tumors
Background:Simultaneous radiochemotherapy (sRCT) is the treatment of first choice in locally advanced head and neck cancers. We… 
1998
1998
Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience
We performed a Phase II trial to evaluate the activity and tolerability of docetaxel as a single agent in the treatment of… 
1997
1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multi…
Primary end point of this trial was to reduce neutropenic infections during the treatment of aggressive NHL with CEOP/IMVP-Dexa… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)